Citation data

OpenCitations

Works that cite this article, indexed by OpenCitations.

15 resultsUpdated October 20, 2026
1

WITHDRAWN: Efficacy and Side Effects of Sofosbuvir and Daclatasvir for Treatment of Hepatitis C in Thalassemia Major Patients with Treatment Experience of Interferon-Based Regimens

Hepatitis Monthly 18(9) (2018)

Jamshid Vafaeimanesh; Fahimeh Safarnezhad Tameshkel; Hossein Ajdarkosh; Azita Azarkeyvani; Mahmoodreza Khoonsari; Amirhossein Faraji; Masoudreza Sohrabi; Sima Aten; Hossein Keyvani; Farhad Zamani

2

Efficacy and Safety of Generic Sofosbuvir/Ledipasvir Fixed-Dose Combination in Iranian Patients with Chronic Hepatitis C Virus Infection

Hepatitis Monthly 17(6) (2017)

Heidar Sharafi; Mehri Nikbin; Seyed Hoda Alavian; Bita Behnava; Seyed Moayed Alavian

3

Next Steps Toward Eradication of Hepatitis C in the Era of Direct Acting Antivirals

Hepatitis Monthly 16(4) (2016)

Khashayar Hesamizadeh; Heidar Sharafi; Mohammad Saeid Rezaee-Zavareh; Bita Behnava; Seyed Moayed Alavian

6

A facile PCR‐RFLP method for genotyping of ITPA rs1127354 and rs7270101 polymorphisms

Journal of Clinical Laboratory Analysis 32(7) (2018)

Seyed Ehsan Alavian; Heidar Sharafi; Paniz Shirmast; Seyed Moayed Alavian; Bita Behnava; Mohammad Pouryasin; Maryam Keshvari; Ali Pouryasin

7

Codon usage of human hepatitis C virus clearance genes in relation to its expression

Journal of Cellular Biochemistry 121(1) (2019)

Pratichi Singh; Arthi Venkatesan; Parasuraman Padmanabhan; Balazs Gulyas; Febin Prabhu Dass J

8

Assessment of Hepatitis C Virus RNA in Peripheral Blood Mononuclear Cells as a Predictor of Response to Pegylated-Interferon and Ribavirin: A Cohort Study

Iranian Red Crescent Medical Journal 19(5) (2017)

Seyyed Mohammad Miri; Heidar Sharafi; Shima Salimi; Farah Bokharaei-Salim; Bita Behnava; Maryam Keshvari; Pegah Karimi Elizee; Hosein Keyvani; Seyed Moayed Alavian

9

Psychiatric side effects of pegylated interferon‑α and ribavirin therapy in Iranian patients with chronic hepatitis C: A meta‑analysis

Experimental and Therapeutic Medicine (2018)

Lotfollah Davoodi; Babak Masoum; Mahmood Moosazadeh; Hamed Jafarpour; Mohammad Haghshenas; Tahoora Mousavi

10

Simeprevir/pegylated interferon/ribavirin triple therapy for recurrent hepatitis C after living donor liver transplantation

Hepatology Research 46(11) (2016)

Masahiro Shinoda; Hirotoshi Ebinuma; Osamu Itano; Yoshiyuki Yamagishi; Hideaki Obara; Minoru Kitago; Nobuhiro Nakamoto; Taizo Hibi; Hiroshi Yagi; Yuta Abe; Kentaro Matsubara; Po‐sung Chu; Yuko Wakayama; Nobuhito Taniki; Akihiro Yamaguchi; Ryusuke Amemiya; Rei Miyake; Takamasa Mizota; Takanori Kanai; Yuko Kitagawa

11

Long-Term Follow-Up of Thalassemia Major Patients with Hepatitis C Virus Treated with Sofosbuvir and Daclatasvir: A Cohort Study

Archives of Medical Research 53(7) (2022)

Fahimeh Safarnezhad Tameshkel; Mohammad Hadi Karbalaie Niya; Bahareh Amirkalali; Nima Motamed; Jamshid Vafaeimanesh; Mansooreh Maadi; Masodreza Sohrabi; Amir Hossein Faraji; Mahmoodreza Khoonsari; Hossein Ajdarkosh; Mehdi Nikkhah; Elham Sobh Rakhashankhah; Farhad Zamani

12

Navigating Evolving Challenges in Blood Safety

Viruses 16(1) (2024)

Mahmoud Reza Pourkarim

13

The Effectiveness of Sofosbuvir and Daclatasvir in the Treatment of Hepatitis C in Thalassaemia Major Patients and their Effect on Haematological Factors

Indian Journal of Medical Microbiology 36(2) (2018)

Farhad Zamani; Hossein Ajdarkosh; Fahimeh Safarnezhad-Tameshkel; Azita Azarkeivan; Hossein Keyvani; Farshad Naserifar; Jamshid Vafaeimanesh

14

THE COURSE OF HEPATITIS C INFECTION AND RESPONSE TO ANTI-VIRAL THERAPY IN PATIENTS WITH THALASSEMIA MAJOR AND HEPATITIS C INFECTION: A LONGITUDINAL, PROSPECTIVE STUDY.

Mediterranean Journal of Hematology and Infectious Diseases 11(1) (2019)

Sanaa Kamal; Sara Abdelhakam; Dahlia Ghoraba; Mohamad Amer Mohsen; Ahmed Abdelsalam; Huda Hassan; Leila Nabeigh